Fundraising Fox
Tabula
8 known investors
Find your way into Tabula
Sign up to see every warm intro you have to Tabula
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tabula team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tabula Bio uses machine learning to design in-context DNA algorithms that can outpace microbial evolution and treat infectious disease, positioning itself as an alternative to traditional antibiotic and drug development. The company applies AI to design new DNA faster than pathogens can evolve resistance, and states it is already treating patients.
Investors · 8
How we know: the company's own site · Not right? Tell us
How we know: Zypsy Capital's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Tabula do?
- Tabula Bio uses machine learning to design in-context DNA algorithms that can outpace microbial evolution and treat infectious disease, positioning itself as an alternative to traditional antibiotic and drug development. The company applies AI to design new DNA faster than pathogens can evolve resistance, and states it is already treating patients.
- Who are Tabula's investors?
- Tabula's investors include Maven Ventures, Zypsy Capital, Balderton Capital, Benchmark, Crosslink Capital, Dag Ventures, Greylock Partners, New Enterprise Associates (NEA).